These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 32450611)

  • 1. Classic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications.
    Chen F; Wu X; Niculite C; Gilca M; Petrusca D; Rogozea A; Rice S; Guo B; Griffin S; Calin GA; Boswell HS; Konig H
    J Cell Mol Med; 2020 Jul; 24(13):7378-7392. PubMed ID: 32450611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model.
    Xu H; Muise ES; Javaid S; Chen L; Cristescu R; Mansueto MS; Follmer N; Cho J; Kerr K; Altura R; Machacek M; Nicholson B; Addona G; Kariv I; Chen H
    J Cell Mol Med; 2019 Oct; 23(10):7063-7077. PubMed ID: 31449347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenylation-dependent Ras inhibition by pamidronate inhibits pediatric acute myeloid leukemia stem and differentiated cell growth and survival.
    Wang C; Liu X; He R; Li J; Pan R
    Biochem Biophys Res Commun; 2019 Sep; 517(3):439-444. PubMed ID: 31376932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
    Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
    Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia.
    Weisberg E; Meng C; Case AE; Tiv HL; Gokhale PC; Buhrlage SJ; Yang J; Liu X; Wang J; Gray N; Adamia S; Sattler M; Stone R; Griffin JD
    J Cell Mol Med; 2020 Mar; 24(5):2968-2980. PubMed ID: 31967735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
    Smith CC; Wang Q; Chin CS; Salerno S; Damon LE; Levis MJ; Perl AE; Travers KJ; Wang S; Hunt JP; Zarrinkar PP; Schadt EE; Kasarskis A; Kuriyan J; Shah NP
    Nature; 2012 Apr; 485(7397):260-3. PubMed ID: 22504184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia.
    Ghasemi M; Okay M; Turk S; Naeemaee R; Guver E; Malkan UY; Aksu S; Sayinalp N; Haznedaroglu IC
    J Renin Angiotensin Aldosterone Syst; 2019; 20(2):1470320319851310. PubMed ID: 31117912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia.
    Gebru MT; Atkinson JM; Young MM; Zhang L; Tang Z; Liu Z; Lu P; Dower CM; Chen L; Annageldiyev C; Sharma A; Imamura Kawasawa Y; Zhao Z; Miller BA; Claxton DF; Wang HG
    Blood; 2020 Aug; 136(9):1067-1079. PubMed ID: 32396937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes.
    An X; Liu J; Wang N; Wang D; Huang L; Zhang L; Cai J; Wery JP; Zhou D; Zhou J; Li QX
    Exp Hematol; 2017 Jan; 45():36-44.e2. PubMed ID: 27670587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
    Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
    Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
    Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
    PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients.
    van der Weide K; de Jonge-Peeters S; Huls G; Fehrmann RS; Schuringa JJ; Kuipers F; de Vries EG; Vellenga E
    Exp Hematol; 2012 Mar; 40(3):177-186.e6. PubMed ID: 22120639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
    Grønningsæter IS; Reikvam H; Aasebø E; Bartaula-Brevik S; Tvedt TH; Bruserud Ø; Hatfield KJ
    Cells; 2020 May; 9(5):. PubMed ID: 32392896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions.
    Chen F; Licarete E; Wu X; Petrusca D; Maguire C; Jacobsen M; Colter A; Sandusky GE; Czader M; Capitano ML; Ropa JP; Boswell HS; Carta F; Supuran CT; Parkin B; Fishel ML; Konig H
    J Cell Mol Med; 2021 Dec; 25(24):11039-11052. PubMed ID: 34791807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia.
    Palma CA; Al Sheikha D; Lim TK; Bryant A; Vu TT; Jayaswal V; Ma DD
    Mol Cancer; 2014 Apr; 13():79. PubMed ID: 24708856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.